Financial & competing interests disclosure
Some of the primary research described in this editorial is supported, in part, by grants P01CA124570 and R01CA118980 from the National Cancer Institute and the Breast Cancer Research Foundation (all to C Eng). J Ngeow is the National Medical Research Council (Singapore) Fellow and an Ambrose Monell Foundation Cancer Genomic Medicine Clinical Fellow at the Cleveland Clinic Genomic Medicine Institute. C Eng is the Sondra J and Stephen R Hardis Chair of Cancer Genomic Medicine at the Cleveland Clinic and is an American Cancer Society Clinical Research Professor, generously funded in part by the FM Kirby Foundation. C Eng receives royalties from Quest Diagnostics for a method to differentiate benign from malignant thyroid neoplasia and is co-PI of a sponsored research grant from IntegraGen for an autism genomic test. She is also an unpaid member of the external advisory boards of GenomOncology, EcoEos.com and Complete Genomics, Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.